Cargando…
ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group’s perspective
There has been no major change of practice in gastrointestinal oncology at the European Society for Medical Oncology (ESMO) symposium 2021, but confirmation that immunotherapy in combination with chemotherapy has become standard of care in several indications. The European Organisation for Research...
Autores principales: | Koessler, T., Alsina, M., Arnold, D., Ben-Aharon, I., Collienne, M., Lutz, M.P., Neuzillet, C., Obermannova, R., Peeters, M., Sclafani, F., Smyth, E., Valle, J.W., Wagner, A.D., Wyrwicz, L., Fontana, E., Moehler, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857487/ https://www.ncbi.nlm.nih.gov/pubmed/35180656 http://dx.doi.org/10.1016/j.esmoop.2022.100392 |
Ejemplares similares
-
Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group
por: Koessler, Thibaud, et al.
Publicado: (2021) -
From the ESMO Congress 2021
por: Sidaway, Peter
Publicado: (2021) -
My personal highlights of ESMO 2016
por: Dediu, M., et al.
Publicado: (2017) -
ESMO20 YO for YO: highlights on upper GI tumours
por: Cardone, C., et al.
Publicado: (2020) -
ESMO 2017—my personal highlights
por: Kiesewetter, Barbara, et al.
Publicado: (2018)